Michal Šimíček
Impact in
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- Mitochondrial Function and Pathology
- Protein Degradation and Inhibitors
- Oncology top 10%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 8
- Protein Degradation and Inhibitors 5
- Glycosylation and Glycoproteins Research 3
- Mitochondrial Function and Pathology 3
- Hematology 12
- Multiple Myeloma Research and Treatments 9
- Co-authors
- David Komander (3 shared papers)Tobias Wauer (1 shared paper)Alexander F. Schubert (1 shared paper)Anna Sablina (4 shared papers)Roman Hájek (19 shared papers)Tomáš Jelı́nek (15 shared papers)Matouš Hrdinka (9 shared papers)Kirby N. Swatek (1 shared paper)
- Journals
- Blood (6 papers)Cancers (2 papers)PLoS ONE (1 paper)British Journal of Haematology (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- CzechiaUnited StatesBelgium
In The Last Decade
Michal Šimíček
27 papers receiving 1.1k citations
Michal Šimíček's Hit Papers
Peers
Comparison fields: 5 of 77
- Molecular Biology 821
- Oncology 284
- Epidemiology 339
- Neurology 124
- Cell Biology 132
Countries citing papers authored by Michal Šimíček
This map shows the geographic impact of Michal Šimíček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Šimíček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Šimíček more than expected).
Fields of papers citing papers by Michal Šimíček
This network shows the impact of papers produced by Michal Šimíček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Šimíček. The network helps show where Michal Šimíček may publish in the future.
Co-authors
The 25 scholars most cited alongside Michal Šimíček, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mechanism of phospho-ubiquitin-induced PARKIN activation Hit paper breakdown → | 2015 | 366 |
| 2 | 2015 | 165 | |
| 3 | 2012 | 103 | |
| 4 | 2016 | 84 | |
| 5 | 2013 | 77 | |
| 6 | 2018 | 72 | |
| 7 | 2018 | 41 | |
| 8 | 2020 | 38 | |
| 9 | 2023 | 30 | |
| 10 | 2010 | 26 | |
| 11 | 2022 | 16 | |
| 12 | 2014 | 13 | |
| 13 | 2021 | 12 | |
| 14 | 2023 | 11 | |
| 15 | 2018 | 10 | |
| 16 | 2020 | 10 | |
| 17 | 2024 | 8 | |
| 18 | 2019 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2023 | 4 |
About Michal Šimíček
Michal Šimíček is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Genetics, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Glycosylation and Glycoproteins Research (3 papers), Mitochondrial Function and Pathology (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Molecular Biology (821 citations), Oncology (284 citations), Epidemiology (339 citations), Neurology (124 citations) and Cell Biology (132 citations). Michal Šimíček has collaborated with scholars based in Czechia, United States and Belgium. Frequent co-authors include David Komander, Tobias Wauer, Alexander F. Schubert, Anna Sablina, Roman Hájek, Tomáš Jelı́nek, Matouš Hrdinka, Kirby N. Swatek, Martin A. Michel and Stefan M.V. Freund. Their work appears in journals such as Blood, Cancers, PLoS ONE, British Journal of Haematology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.